Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03270462 · ClinicalTrials.gov registry record · Phase 4
CNS Study of Patients Switching From Tacrolimus to Envarsus
A Phase 4 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT03270462 is a Phase 4 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 20 participants.
The verdict
NCT03270462, a Phase 4 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a pilot study documenting the neurotoxic side effects including tremors in patients with a stable graft who are receiving Tacrolimus following kidney transplantation. A standardized questionnaire will be used to document these symptoms.
Interventions
- DRUG Envarsus XR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2020-06-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03270462
The ClinicalTrials.gov registry entry for NCT03270462 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Envarsus XR is the first listed.
NCT03270462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03270462 about?
NCT03270462 is a clinical study titled "CNS Study of Patients Switching From Tacrolimus to Envarsus". This is a pilot study documenting the neurotoxic side effects including tremors in patients with a stable graft who are receiving Tacrolimus following kidney transplantation. A standardized questionnaire will be used to document these symptoms.
What is the current status of trial NCT03270462?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2017-12-01. Estimated completion is 2020-06-02.
What interventions are being tested in trial NCT03270462?
The interventions under investigation include: Envarsus XR (DRUG).
Who is sponsoring clinical trial NCT03270462?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.